The Patent Finder
US

Enhanced Bioavailability of Polyunsaturated Fatty Acids

US 9,895,333 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Oct 9, 2020 (Midcap Funding IV Trust).

Term ends Oct 29, 2034 · High confidence

Filed Jun 25, 2015 as application 14/749,671 · Granted Feb 20, 2018
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Oct 29, 2014
Term ends
Oct 29, 2034
Granted
Feb 20, 2018
base term fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,895,332, to Oct 29, 2034. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
31
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 29, 2014, when applications 14/527,201 and PCT/US2014/062892, the earliest non-provisional applications in its chain, were filed (this one was filed Jun 25, 2015)Oct 29, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,895,332)resolves to Oct 29, 2034, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 29, 2034High confidence

This family

US 9,895,332In force
Oct 2034
Oct 2034
Application PCT/US2014/062892PCT application
no patent term
no patent term
US 9,326,965In force
Feb 2035
Feb 2035
Application PCT/US2015/017893PCT application
no patent term
no patent term
Application 62/138,468Pending
not computed
not computed
US 9,895,333this patent
Oct 2034
Oct 2034
Application PCT/US2015/037558PCT application
no patent term
no patent term
US 9,326,947In force
Feb 2035
Feb 2035
8 of 31 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 4, 2015
Reel 37211, frame 968
Bionpharma Healthcare LLC (as Licensee from Banner Life Sciences, LLC)Midcap Financial Trust, As AgentSecurity Interest (REVOLVER)
Dec 4, 2015
Reel 37212, frame 135
Bionpharma Healthcare LLC (as Licensee from Banner Life Sciences, LLC)Midcap Financial Trust, As AgentSecurity Interest (TERM)
Jan 4, 2016
Reel 37399, frame 659
Bionpharma Inc.; Bionpharma Healthcare LLCAthyrium Opportunities II Acquisition LPSecurity Interest
Jun 29, 2017
Reel 43032, frame 619
Banner Life Sciences LLCPatheon Softgels Inc.Nunc Pro Tunc Assignment
Oct 9, 2020
Reel 54036, frame 121
Bionpharma Healthcare LLC (as Licensee from Patheon Softgels Inc.)Midcap Financial Trust, As AgentSecurity Interest (TERM)
Oct 9, 2020
Reel 54036, frame 260
Bionpharma Healthcare LLC (as Licensee from Patheon Softgels Inc.)Midcap Funding IV Trust, as AgentAmended and Restated Security Interest (REVOLVING)
Dec 8, 2020
reel/frame not recorded
Athyrium Opportunities II Acquisition LPBionpharma Inc.Release of Security Interest
Dec 8, 2020
reel/frame not recorded
Athyrium Opportunities II Acquisition LPBionpharma Healthcare LLCRelease of Security Interest
Dec 8, 2020
Reel 54575, frame 365
Athyrium Opportunities II Acquisition LPBionpharma Inc.; Bionpharma Healthcare LLCRelease of Security Interest
Feb 1, 2021
reel/frame not recorded
Midcap Financial TrustBionpharma Healthcare LLCRelease of Security Interest
Feb 1, 2021
reel/frame not recorded
Midcap Financial TrustBionpharma Health Inc.Release of Security Interest
Feb 1, 2021
reel/frame not recorded
Midcap Financial TrustBionpharma Inc.Release of Security Interest
Feb 1, 2021
Reel 55100, frame 105
Midcap Financial TrustBionpharma Healthcare LLC; Bionpharma Health Inc.; Bionpharma Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited